ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Neox s.r.o., a European-based CRO. Neox will add over 150 employees who support biotechnology, pharmaceutical, and medical device companies.
"This is an important and exciting step for Emmes, demonstrating significant progress on our strategic plans to grow our biopharmaceutical business," said Dr. Christine Dingivan, Chief Executive Officer of Emmes. "Neox adds a sizable, well-established biopharmaceutical research services business to Emmes and significantly expands our international presence."